S

Samsung Biologics
A207940

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
₩86.90T
EV
₩86.68T
Shares Outstanding
46.29M
Beta
0.16
Industry
Biotechnology

Wall Street View

Analyst Rating
BUY
Analyst Target Price
Number of Analysts
26
P/E 2025E
52.63x
P/Revenue 2025E
14.88x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Samsung Biologics Co.,Ltd.

gainify

S

Samsung Biologics Co.,Ltd.

A207940

Samsung Biologics Co.,Ltd. engages in the contract development and manufacturing organization (CDMO) business for biopharmaceuticals products in South Korea, Europe, the United States, and internationally. The company operates in two segments, CDMO, and Biopharmaceuti...

Sector

Healthcare

Industry

Biotechnology

CEO

Rim, John Chongbo

Employees

5,047

IPO Date

2016-11-11

Headquarters

300, Songdobio-daero, Yeonsu-gu, Incheon 21987, South Korea

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.